Noribogaine reduces nicotine self-administration in rats

Noribogaine, a polypharmacological drug with activities at opioid receptors, ionotropic nicotinic receptors, and serotonin reuptake transporters, has been investigated for treatment of substance abuse-related disorders. Smoking cessation has major benefits for both individuals and society, therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Qing, Hanania, Taleen, Mash, Deborah C, Maillet, Emeline L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456428/
https://www.ncbi.nlm.nih.gov/pubmed/25995321
http://dx.doi.org/10.1177/0269881115584461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456428/
https://www.ncbi.nlm.nih.gov/pubmed/25995321
http://dx.doi.org/10.1177/0269881115584461

Ejemplares similares